MKI67 and neoplasm: Age, sex, concomitant therapies, surgical approach, imaging method, median time to recurrence or progress, and tumour burden at the time of recurrence or progress did not differ significantly between the three groups, whereas resection status, ENSAT stage, preoperative hormone excess, Ki67 index, primary tumour size, and follow-up time were significantly different between the groups (see Table 1).